Hybrid Conferencee

International Conference on Biomarkers and Radiology in Cancer (ICBRC - 26)

3rd - 4th September 2026 | Bejaia, Algeria

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Bejaia. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Bejaia event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Bejaia conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Bejaia, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Bejaia."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in MRI and CT Imaging Techniques

This track focuses on the latest developments in MRI and computed tomography imaging technologies for cancer diagnosis. It aims to explore their applications in enhancing the accuracy and efficacy of cancer detection.

Track 02

Innovations in PET Imaging for Cancer Detection

This session will delve into the advancements in positron emission tomography (PET) imaging, particularly in its integration with CT and MRI. Participants will discuss the implications of hybrid imaging techniques on cancer diagnosis and treatment planning.

Track 03

Biomarkers in Breast and Lung Cancer

This track will investigate the role of biomarkers in the early detection and management of breast and lung cancers. Emphasis will be placed on the identification of novel biomarkers and their potential for personalized treatment strategies.

Track 04

Biomarkers in Prostate and Blood Cancers

This session will explore the significance of biomarkers in the diagnosis and treatment of prostate and blood cancers. Discussions will include the latest research findings and their implications for clinical practice.

Track 05

Biomarkers in Colorectal and Ovarian Cancers

This track will focus on the discovery and validation of biomarkers specific to colorectal and ovarian cancers. The session aims to highlight their potential in improving patient outcomes through targeted therapies.

Track 06

Targeted Therapies and Immunotherapy in Cancer Treatment

This session will examine the rationale behind targeted therapies and immunotherapy in cancer treatment. Participants will discuss the latest evidence supporting their use and the challenges faced in clinical implementation.

Track 07

Combining Radiotherapy with Novel Therapeutic Approaches

This track will address the integration of radiotherapy with novel therapeutic strategies, including immunotherapy and targeted treatments. The focus will be on optimizing treatment regimens to enhance patient outcomes.

Track 08

Androgen Manipulation and T-cell Modulation in Cancer Therapy

This session will explore the mechanisms and clinical applications of androgen manipulation and T-cell modulation in cancer therapy. Discussions will include their roles in improving treatment efficacy and patient survival.

Track 09

Human Cancer Stem Cells and Immune Biological Properties

This track will investigate the immune biological properties of human cancer stem cells and their implications for cancer treatment. Participants will discuss potential therapeutic targets and strategies for overcoming resistance.

Track 10

Innovative Approaches to Immunotherapy in Cancer Treatment

This session will focus on novel phosphatidyl service targeting and bite antibodies in cancer immunotherapy. The aim is to explore their applications in treating solid tumors and enhancing immune responses.

Track 11

Targeting the Myeloma Microenvironment with Immunotherapy

This track will examine strategies for targeting the myeloma microenvironment using immunotherapy. Discussions will focus on the challenges and opportunities in developing effective treatments for myeloma patients.